MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study

    N. Holland, S. Jones, J. Woodside, E. Jabbari, V. Chelban, A. Costantini, PN. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, H. Morris, J. Rowe (Cambridge, United Kingdom)

    Objective: To investigate grey matter volume in typical and variant Parkinson-plus syndromes, to correlate these with disease severity, and to assess regional atrophy within disease…
  • 2019 International Congress

    18F-DPA714 PET reveals neuroinflammatory activity in the Substantia nigra of patients with Parkinson disease

    S. Lavisse, C. Wimberley, S. Goutal, M. Bottlaender, B. Kuhnast, MA. Peyronneau, M. Sarazin, P. Hantraye, C. Thiriez, P. Remy (Fontenay Aux Roses, France)

    Objective: We investigated whether 18F-DPA714 imaging could be a sensitive marker of neuroinflammation in Parkinson disease (PD). We took into account the polymorphism of TSPO…
  • 2019 International Congress

    Is 18F-FDG-PET/CT a helpful tool to diagnose PSP clinical variants?

    G. Marti-Andres, M. Riverol-Fernandez, R. Valentí-Azcárate, M. Fernández-Matarrubia, E. Prieto-Azcárate, J. Arbizu-Azcarate, MR. Luquin-Piudo (Pamplona, Spain)

    Objective: To assess if there are differential metabolic brain patterns among Progressive Supranuclear Palsy(PSP) clinical variants and between them and Parkinson’s disease patients (PD). Background:…
  • 2019 International Congress

    Probing Error Signals of Postural Control in Fragile X Premutation carriers

    C. O'Keeffe, M. Carro Domínguez, E. O'Rourke, N. Feerick, T. Lynch, R. Reilly (Dublin, Ireland)

    Objective: This study aimed to characterize cortical theta activity in Fragile X Premutation carriers during continuous balance. Background: Fragile X Associated Tremor/Ataxia Syndrome (FXTAS) is…
  • 2019 International Congress

    Could we optimize the stimulation parameters setting of directional leads with a patient-specific imaging software in implanted parkinsonian patients?

    AS. Rolland, N. Carriere, G. Touzet, L. Defebvre, N. Reyns, D. Devos, C. Moreau (Lille Cedex, France)

    Objective: Deep brain stimulation in the subthalamic nucleus (STN) is routinely proposed to parkinsonian patients. Introduction of directional leads offer more flexibility for programming but…
  • 2019 International Congress

    Resting state Functional Connectivity differences in Pediatric Patients with Tourette syndrome and Obsessive-compulsive disorder

    S. Tikoo, F. Cardona, S. Tommasin, C. Giannì, N. Upadhyay, K. Bharti, G. Conte, G. Mirabella, A. Suppa, P. Pantano (Roma, Italy)

    Objective: To assess functional connectivity (FC) abnormalities contributing to the pathophysiology of Tourette syndrome (TS) and obsessive-compulsive disorder (OCD) in pediatric patients. Background: TS is…
  • 2019 International Congress

    EEG guided neurofeedback boosts effects of motor cortex neuromodulation of rTMS in Parkinson´s Disease Patients

    J. Romero, A. Arroyo, J. Andreo, M. Del Castillo, J. Serrano, E. Rocon, N. Malpica, E. Melero, E. Sanz, M. Gil, E. Rodriguez (Madrid, Spain)

    Objective: To compare the clinical and neurophysiological effects of EEG guided Neurofeedback (NFB) vs 10Hz rTMS vs combined therapy (NFB+rTMS) in motor cortex of non-demented…
  • 2019 International Congress

    Day Hospitals Reinvented : the future of Parkinson’s care

    J. Adenwalla, S. Jones, M. Oliver, N. Noushad, B. Mohamed, C. Thomas, T. Williams, S. Mahon (Cardiff, United Kingdom)

    Objective: To evaluate our model of delivering inter-disciplinary, patient-focused care in an outpatient environment. Background: The progressive and potential debilitating nature of Parkinson’s makes early…
  • 2019 International Congress

    Adult-Onset Parainfectious Opsoclonus-Myoclonus: Report of Two Cases

    MI. Gaston, I. Rubio, J. Muruzabal, R. Larumbe, M. Martin, L. Martinez (Pamplona, Spain)

    Objective: Present two cases of Adult-Onset parainfectious Opsoclonus-Myoclonus Syndrome with fast and good recovery Background: Adult-Onset Opsoclonus-Myoclonus  (AOMS) is a rare disorder. Two main causes…
  • 2019 International Congress

    Correlation between substantia nigra measurement and UPDRS

    N. Mohammadzade, F. Omrani, A. Habibi (Tehran, Islamic Republic of Iran)

    Objective: Parkinson is mainly developed due to neurodegeneration of substantia nigra pars compacta (SNpc).the aim of our study was to check if there is any correlation between the size…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley